Top Markets
Coin of the day
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXV
Rangering i aksjer #38547
BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company... BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen. These partnerships are geared towards the advancement and commercialization of nanosized antibodies (NanoAbs), including a specific candidate for COVID-19, and extending this technology to address various other disease indications. Founded in 2003, BiondVax maintains its corporate headquarters in Jerusalem, Israel.
Aksjekurs
$0.8
Sist synkronisert: 2023-10-03
Markedsverdi
$922.40K
Endring (1 dag)
-5.88%
Endring (1 år)
0.00%
Land
IL
Handel BiondVax Pharmaceuticals Ltd. (BVXV)

Kategori

Utbytteavkastning for BiondVax Pharmaceuticals Ltd. (BVXV)
BiondVax Pharmaceuticals Ltd. (aksjesymbol: BVXV) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for BiondVax Pharmaceuticals Ltd. (BVXV) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter